Vertex Pharmaceuticals Inc. / MA (VRTX) earnings: date, estimates and history
Price $538.60 · data as of November 13, 2026
Next earnings report
The date appears here once Vertex Pharmaceuticals Inc. / MA confirms it, usually two to four weeks before the report.
Track record
Vertex Pharmaceuticals Inc. / MA beat the consensus earnings estimate in 2 of its last 4 reports, by +2.0% on average. On report days the stock moved 1.6% on average, up or down.
Earnings history
| Reported | EPS estimate | EPS actual | Surprise | Revenue | Revenue growth | Stock move |
|---|---|---|---|---|---|---|
| November 2, 2026 Sep/2026 | $4.78 | $4.76 | −0.5% | $3.4B | — | −5.0% |
| August 3, 2026 Jun/2026 | $4.75 | $4.73 | −0.3% | $3.3B | +12.5% | +0.3% |
| May 4, 2026 Mar/2026 | $4.31 | $4.47 | +3.8% | $3.0B | +7.8% | +0.1% |
| November 3, 2025 Sep/2025 | $4.58 | $4.80 | +4.9% | $3.1B | +11.0% | −0.9% |
EPS as compared with analyst estimates (adjusted EPS). Revenue growth is against the same quarter a year earlier. Stock move: change on the first trading day after the report.
Frequently asked questions
When is Vertex Pharmaceuticals Inc. / MA’s next earnings date?
Vertex Pharmaceuticals Inc. / MA has not confirmed its next report date yet. Its last report was on November 2, 2026.
Did Vertex Pharmaceuticals Inc. / MA beat earnings last quarter?
No, it reported EPS of $4.76 on November 2, 2026 against an estimate of $4.78 (a −0.5% surprise), and the stock moved −5.0% the next trading day.
What EPS do analysts expect next quarter?
The consensus estimate is $4.10 per share on revenue of about $3.5B.
Report dates and estimates from analyst consensus data; results from company reports. Updated daily. Not investment advice. Earnings calendar